Non-Hodgkin's lymphoma

Pediatric Clinics of North America

Volumn 44, Issue 4, 1997, Pages 863-890

  Shad, A ^a   Magrath, I ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

BRAIN TUMOR; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC ACCURACY; EPIDEMIOLOGICAL DATA; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PROGNOSIS; REVIEW; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT PLANNING;

EID: 0030756425     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70534-4     Document Type: Article

References (147)

1. J.R. Anderson D.T. Jenkin J.F. Wilson Long term follow up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkins lymphoma: A report of CCG-551 from the Childrens Cancer Group J Clin Oncol 11 1993 1024 1032
2. P.D. Aplan D.P. Lombardi A.M. Ginsberg Disruption of the human SCL locus by “illegitimate” V-(D)-J recombinase activity Science 7 1990 1426 1429
3. F. Appelbaum K. Sullivan E. Thomas Treatment of malignant lymphoma in one hundred patients with chemotherapy, total body irradiation and marrow transplantation J Clin Oncol 7 1989 1288 1294
4. J.O. Armitage Chemotherapy for non-Hodgkin's lymphoma Curr Opin Oncol 5 1992 840
5. J.C. Arseneau G.P. Canellos P.M. Banks American Burkitt's lymphoma: A clinicopathological study of 30 cases. I: Clinical factors relating to long term survival Am J Med 58 1975 314 321
6. K.D. Bagshawe Antibody-directed enzyme/prodrug therapy (ADEPT) Biochem Soc Trans 18 1990 750 752
7. A. Bernard L. Boumsell C. Patte Leukemia versus lymphoma in children: A worthless question? Med Pediatr Oncol 14 1986 148 157
8. A. Bernard S.B. Murphy S. Melvin Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor Blood 59 1982 549 554
9. O. Bernard P. Guglielmi P. Jonveaux Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias Genes-Chromosomes-Cancer 1 1990 194 208
10. A. Bernheim R. Berger G. Lenoir Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations Cancer Genet Cytogenet 3 1981 307 315
11. K. Bhatia M.I. Raj M.I. Guiterrez Variation in the sequence of EBV nuclear antigen-1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas Oncogene 13 1996 177 181
12. K. Bhatia K. Huppi G. Spangler Point mutations in the transactivation domain of c-myc are common in Burkitt's lymphoma and mouse plasmacytomas Nature Genetics 5 1993 56 61
13. J.Y. Blay D. Louis E. Bouffet Management of pediatric non-Hodgkin's lymphoma Blood Reviews 5 1991 90
14. T. Boehm L. Foroni Y. Kaneko The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13 Proc Natl Acad Sci USA 88 1991 4367 4371
15. T. Boehm T.H. Rabbitts The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors FASEB-J 3 1989 2344 2359
16. W.P. Bowman J.J. Shuster B. Cook Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small non-cleaved cell lymphoma: A Pediatric Oncology Group Study J Clin Oncol 14 1996 1252 1261
17. R.M. Braziel T. Keneklis J.A. Donlon Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma Am J Clin Pathol 80 1983 655 659
18. L. Brown J.T. Cheng Q. Chen Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia EMBO J 9 1990 3343 3351
19. G. Brubaker A.G. Levin C.M. Steel Multiple cases of Burkitts lymphoma and other neoplasms in the families of the N Mara district of Tanzania Inter J Cancer 26 1980 165 170
20. N.J. Bunin E. Hvizdala M. Link Mediastinal nonlymphoblastic lymphomas in children: A clinicopathologic study J Clin Oncol 4 1986 154 159
21. D.P. Burkitt General features and facial tumours D.P. Burkitt D.H. Wright Burkitt's Lymphoma 1970 Livingstone Edinburgh 6 15
22. D. Burkitt Long term remissions following one and two dose chemotherapy for African lymphoma Cancer 20 1967 756 759
23. R.C. Chasty J.A. Luin-Yin Acute tumor lysis syndrome Br J Hosp Med 49 1993 488
24. Q. Chen C.Y. Yang J.T. Tsan Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia J Exp Med 172 1990 1403 1408
25. H.C. Clevers M.J. Owen Towards a molecular understanding of T-cell differentiation Immunol-Today 12 1991 86 92
26. M.S. Co C. Queen Humanized antibodies for therapy Nature 351 1991 501 502
27. L.F. Cohen J.E. Balow I.T. Magrath Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma Am J Med 68 1980 486 491
28. P. Colombat P. Biron C. Patte High-dose etoposide and cisplatin in refractory or recurrent non-Hodgkin's lymphomas (NHL) Nouv Rev Fr Hematol 32 1990 183 186
29. J. Cossman T.M. Chused R.I. Fisher ES: Diversity of immunological phenotypes of lymphoblastic lymphoma Cancer Res 43 1983 4486 4490
30. F.E. Craig N. Clare J. Sklar T cell lymphoma and the virus associated hemophagocytic syndrome Am J Clin Pathol 97 1992 189 194
31. G. Csako I.T. Magrath R. Elin Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma Am J Clin Pathol 78 1982 712 717
32. R. Dalla-Favera M. Bregni J. Erikson Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc Natl Acad Sci USA 79 1982 7824 7827
33. I.D. Dube S.C. Raimondi D. Pi A new translocation, t(10;14)(q24;q11), in T cell neoplasia Blood 67 1986 1181 1184
34. O.B. Eden I. Hann J. Imeson Treatment of advanced stage T cell lymphoblastic lymphoma: Results of the UK-CCSG protocol 8503 Br J Hematol 83 1992 310
35. G. Evan E. Harrington A. Fanidi Integrated control of cell proliferation and cell death by the c-myc oncogene Philos Trans R Soc Lond B Biol Sci 345 1994 269 275
36. M. Favrot T. Philip Bone marrow purging I.T. Magrath New Directions in Cancer Treatment 1989 Springer Verlag Heidelberg 34 43
37. A.H. Filipovitch A. Mertens L. Robison Lymphoproliferative disorders associated with immunodeficiency I.T. Magrath The Non-Hodgkin's Lymphomas ed. 2 1996 Edward Arnold London in press
38. S. Finch Ionizing radiation and drugs in the pathogenesis of lymphoid neoplasia I.T. Magrath G. O'Conor B. Ramot Pathogenesis of Leukemias and Lymphomas: Environmental Influences 1984 Raven Press New York 207 223
39. D.R. Fleming M.A. Doukas Acute tumor lysis syndrome in hematological malignancies Leukemia and Lymphoma 8 1992 315
40. L. Foroni J. Foldi E. Matutes Alpha, beta and gamma T-cell receptor genes: Rearrangements correlate with haematological phenotype in T cell leukaemias Br J Haematol 67 1987 307 318
41. H. Gadner S. Muller-Weihrich H. Riehm Treatment strategies in malignant non-Hodgkin lymphomas in childhood Onkologie 9 1986 126 130
42. J.-C. Gentet C. Patte E. Quintana Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: A study of the French Society of Pediatric Oncology J Clin Oncol 8 1990 661 665
43. T.C. Griffin P.W. Bowman N.J. Winick Treatment of advanced stage, diffuse, small non cleaved cell lymphomas in childhood: Further experience with Total Therapy B Med Pediatr Oncol 23 1994 393
44. T. Grogan C. Spier D.P. Wirt Immunologic complexity of lymphoblastic lymphoma Diagn Immunol 4 1986 81 88
45. W. Gu K. Bhatia I. Magrath p-107 binds and suppresses the c-myc transcriptional activation domain: Tumor derived c-myc mutants escape suppression Science 264 1994 251 254
46. M. Gutierrez K. Bhatia R. Barriga Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint locations and EBV association Blood 79 1992 3261 3266
47. M. Gutierrez J.G. Judde I.T. Magrath Switching viral latency to viral lysis: A novel therapeutic approach for EBV associated neoplasia Cancer Res 56 1996 969 972
48. T. Haddy R. Parker I.T. Magrath Bone marrow involvement in young patients with non-Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate staging Med Ped Oncol 17 1989 418 423
49. T.B. Haddy M.A. Adde I.T. Magrath Central nervous system involvement in small non-cleaved cell lymphoma: Is CNS disease per se a poor prognostic sign? J Clin Oncol 9 1991 1973 1982
50. A. Hagenbeek T. Philip D. Bron The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as of 15 January 1991: 153 patients) Bone Marrow Transplant 7 Suppl 2 1991 142
51. S. Halpern J. Chatten A.T. Meadows Anterior mediastinal masses: Anesthesia hazards and other problems J Pediatr 102 1983 407 410
52. K.R. Hande G.C. Garrow Acute tumor lysis syndrome in patients with high grade non-Hodgkin's lymphoma Am J Med 94 1994 133
53. N.L. Harris E.S. Jaffe H. Stein A Revised European American Classification of lymphoid neoplasms: A proposal from the international lymphoma study group Blood 84 1994 1361
54. H. Herbst G. Tippelmann I. Anagnostopoulos Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype Leuk Res 13 1989 103 116
55. E.V. Hvizdala C. Berard T. Callihan Nonlymphoblastic lymphoma in children—histology and stage-related response to therapy: A Pediatric Oncology Group study J Clin Oncol 9 1991 1189 1195
56. U. Iverson O.H. Iverson J.L. Ziegler Cell kinetics of African cases of Burkitt's lymphoma: A preliminary report Eur J Cancer 8 1972 305 310
57. J.G. Judde G. Spangler I. Magrath The use of EB virus associated genes as determinants in targeting molecular therapy of EBV associated neoplasia Human Gene Therapy 7 1996 646 653
58. M.E. Kadin M.C. Kinney Pathogenesis of Ki-1+ lymphomas I.T. Magrath The Non-Hodgkin's Lymphomas ed. 2 1996 Arnold London 443 458
59. G. Klein Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors Genes Chromosom Cancer 1 1989 3 8
60. A.D. Krudy N.R. Dunnick I.T. Magrath CT of American Burkitt's lymphoma Am J Radiol 136 1981 747 754
61. J.T. Sandlund V. Santana M. Abramovich Large cell non-Hodgkins lymphomas of childhood: Clinical characteristics and outcome Leukemia 8 1994 30 34
62. M.P. LaQuaglia C.G.H. Stolar M. Krailo The role of surgery in abdominal non-Hodgkin's lymphoma: Experience from the Children's Cancer Study Group J Pediatr Surg 27 1992 230 235
63. S.J. Lauer J. Ochs B. Pollock Recombinant alpha-2B interferon treatment for childhood T-lymphoblastic disease in relapse Cancer 74 1994 197
64. G. Laurent J. Pris J.P. Farcet Effects of therapy with T101 ricin A-chain immunotoxin called DA7 Cancer Res 52 1992 1314
65. M.M. Le Beau M.A. Bitter R.A. Larson The t(2;5) (p23;q35): A recurring chromosomal abnormality in Ki-1+ anaplastic large cell lymphoma Leukemia 3 1989 866
66. M.P. Link S.S. Donaldson C.W. Berard Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy N Engl J Med 322 1990 1169 1174
67. M. Link R. Warnke J. Finlay A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies Blood 62 1983 722 728
68. M.P. Link M. Roper R.F. Dorfman Cutaneous lymphoblastic lymphoma with pre-B markers Blood 61 1983 838 841
69. M.P. Link J.J. Shuster C.W. Berard Nine weeks of chemotherapy without radiotherapy is sufficient treatment for most children with localized non-Hodgkin's lymphoma [abstract] Proc Am Soc Clin Oncol 12 1993 1309
70. M. Lu I. Dube S. Raimondi A. Carroll Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukemia: Further evidence for illegitimate physiological recombination Genes Chromosom Cancer 2 1990 217 222
71. F.F. Madanat S.S. Amr M.S. Tarawneh Burkitt's lymphoma in Jordanian children: Epidemiological and clinical study J Trop Med and Hyg 89 1986 189 191
72. I.T. Magrath Small non-cleaved cell lymphomas I.T. Magrath The Non-Hodgkin's Lymphomas ed. 2 1996 Arnold London 781 812
73. I.T. Magrath The treatment of pediatric lymphomas: Paradigms to plagiarize Ann Oncol 8 suppl 1 1997 s1 s8
74. I.T. Magrath The pathogenesis of Burkitt's lymphoma Recent Adv in Cancer Res 55 1990 133 270
75. I.T. Magrath M. Adde A. Shad Adults and children with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen J Clin Oncol 14 1996 925 934
76. I.T. Magrath K. Bhatia B. Huber Genetic intervention in the control of neoplasia Developmental Biology and Cancer 1992 CRC Press Boca Raton, FL 479 523
77. I.T. Magrath Y.J. Lee T. Anderson Prognostic factors in Burkitt's lymphoma: Importance of total tumor burden Cancer 45 1980 1507 1515
78. I.T. Magrath Malignant lymphomas A.S. Levine Cancer in the Young 1982 Masson New York 473 574
79. I. Magrath V. Jain E. Jaffe The small non-cleaved cell lymphomas D. Knowles Neoplastic Hematopathology 1992 Williams & Wilkins Baltimore 749
80. I.T. Magrath K. Bhatia The pathogenesis of small non cleaved cell lymphomas I.T. Magrath The Non-Hodgkin's Lymphomas ed. 2 1996 Arnold London 385 410
81. I.T. Magrath E. Sariban Clinical Features of Burkitt's Lymphoma in the USA: Proceedings: Burkitt's Lymphoma—A Human Cancer Model 1985 IARC Publications France, Lyon 119 127
82. I.T. Magrath Lymphocyte differentiation pathways: An essential basis for the comprehension of lymphoid neoplasia J Natl Cancer Inst 67 1981 501 514
83. I.T. Magrath African Burkitt's lymphoma: History, biology, clinical features, and treatment Am J Ped Hem Onc 13 1991 222 246
84. I.T. Magrath S. Lwanga W. Carswell Surgical reduction of tumour bulk in management of abdominal Burkitt's lymphoma Br Med J 2 1974 308 312
85. I. Magrath C. Janus B. Edwards An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults Blood 63 1984 1102 1111
86. M. Markman Common complications and emergencies associated with cancer and its therapy Clev Clin J Med 61 1994 105
87. D.Y. Mason C. Bastard R. Rimokh CD30+ large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35 Br J Hematol 74 1990 161
88. D. Mathieu-Mahul F. Sigaux C. Zhu A t(8;14)(q24;q11) translocation in a T-cell leukemia (L1-ALL) with c-myc and TCR-alpha chain locus rearrangements Int J Cancer 38 1986 835 840
89. T.W. McKeithan E.A. Shima M.M. Le Beau Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T cell receptor alpha-chain gene and sequences on the 3′ side of MYC Proc Nat Acad Sci USA 83 1986 6636 6640
90. P.A. Meyers V.P. Potter N. Wollner Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma Cancer 56 1985 259 261
91. S.W. Morris M.N. Kirstein M.B. Valentine Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma Science 263 1994 1281 1284
92. B.U. Mueller A.T. Shad I.T. Magrath Malignancies in children with HIV infection P.A. Pizzo C.M. Wilfert Pediatric AIDS: The Challenge of HIV Infection in Infants, Children and Adolescents 1993 Williams & Wilkins Baltimore 603 622
93. S. Mu¨ller-Weihrich G. Henze H.J. Langermann Childhood B-cell lymphomas and leukemias: Improvement of prognosis by a therapy developed for B-neoplasms by the BMF study group Onkologie 7 1984 205 208
94. Mu¨ller-Weihrich S, Henze G, Odenwald E, et al: BFM trials for childhood non-Hodgkin's lymphomas. In Cavalli F, Bonadonna G, Rozenswieg M (eds): Malignant Lymphomas and Hodgkin's disease: Experimental and Therapeutic Advances. 1985, pp 633–642
95. S.B. Murphy The management of childhood non-Hodgkin's lymphoma Cancer Treat Rep 61 1977 1161 1173
96. S. Murphy W.P. Bowman M. Abromowitch Results of treatment of advanced stage Burkitt's lymphoma and B-cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine J Clin Onc 4 1986 1732 1739
97. S.B. Murphy I. Magrath Pediatric lymphomas: Current results and prospects Ann Oncol 2 suppl 2 1991 219 223
98. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas Summary and description of a working formulation for clinical usage Cancer 49 1982 2112 2135
99. C. Patte C. Kalifa F. Flamant Results of the LMB-81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B cell (lymphoblastic lymphoma) Med Pediatr Oncol 20 1992 105
100. C. Patte J. Michon E. Bouffet High survival rate of B-cell childhood lymphoma and leukemia as a result of the LMB-89 protocol of the SFOP program [abstract] Proc Am Soc Clin Oncol 11 1992 340
101. C. Patte T. Philip C. Rodary High survival rate in advanced-stage B cell lymphomas and leukemias without CNS involvement with short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children J Clin Oncol 9 1991 123 132
102. C. Patte T. Philip C. Rodary Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society J Clin Oncol 4 1986 1219 1226
103. P.-G. Pelicci D.M. Knowles II A.A. Zalmen Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders: Implications for lymphomagenesis J Exp Med 164 1986 2049 2076
104. T. Philip P. Biron I. Philip Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: A 5-year experience) Eur J Cancer Clin Oncol 22 1986 1015 1027
105. G.A. Rappold H. Hameister T. Cremer c-myc and immunoglobulin kappa light chain constant genes are on the 8q+ chromosome of three Burkitt lymphoma lines with t(2;8) translocations EMBO J 3 1984 2951 2955
106. A. Reiter M. Schrappe R. Parwaresch Non-Hodgkin's lymphoma of childhood and adolescence: Results of a treatment stratified for biological sub-types and stage-a report of the BFM group J Clin Oncol 13 1995 359
107. A. Reiter M. Schrappe M. Tiemann Successful treatment strategy for Ki-1 anaplastic large cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in 3 consecutive BFM Group studies J Clin Oncol 12 1994 899
108. A. Reiter W. Zimmerman M. Zimmerman The role of initial laparotomy and second look surgery in the treatment of abdominal B-cell non-Hodgkin's lymphoma of childhood: A report of the BFM group Eur J Pediatr Surg 4 1994 74
109. I.J. Su A.L. Cheng M.E. Kadin Retinoic acid induced differentiation and regression of cutaneous Ki-1 anaplastic lymphoma: In vivo and in vitro observations Lab Invest 70 1994 144A
110. L.A. Ries R.W. Miller M. Smith Cancer in children (ages 0–14 and ages 0–19) B. Miller L.A. Ries B. Hankey SEER Cancer Statistics Review 1973–1990 US Dept of Health and Human Services, National Institutes of Health Bethesda, MD
111. A. Rolink F. Melchers Molecular and cellular origins of B lymphocytoid diversity Cell 66 1991 1081 1094
112. J.T. Sandlund W.M. Crist M. Abromowitch Pleural effusion is associated with a poor treatment outcome in stage III small non-cleaved cell lymphoma Leukemia 5 1991 71 74
113. J.T. Sandlund C.H. Pui V.M. Santana Clinical features and treatment outcome for children with CD30+ large cell non-Hodgkin's lymphoma J Clin Oncol 12 1994 895
114. E. Sariban A. Donahue I.T. Magrath Jaw involvement in American Burkitt's lymphoma Cancer 53 1984 141 146
115. E. Sariban C. Janus B. Edwards Central nervous system involvement in American Burkitt's lymphoma J Clin Oncol 11 1983 677 681
116. A. Shad Complications in the management of non-Hodgkin's lymphoma I.T. Magrath The Non-Hodgkin's Lymphomas ed. 2 1996 Arnold London 597 630
117. Shad A, Magrath I: Diagnosis and treatment of non-Hodgkin's lymphoma in childhood. In Wernik P, Canellos G, Dutcher J, Kyle R (eds): Neoplastic Diseases of the Blood, ed. 3. 1996, pp 925–962
118. A. Shad I. Magrath Malignant non-Hodgkin's Lymphomas in Children P. Pizzo D. Poplack Principles and Practice of Pediatric Oncology, Third Edition 1996 Lippincott-Raven Philadelphia 545 587
119. A. Shad M. Adde I.T. Magrath Results of NCI protocol 77-04 for treatment of lymphoblastic lymphoma in children Blood 82 Suppl 1 1993 387a
120. A. Shad K. Bhatia N. Hamdy Pediatric HIV associated non Hodgkins lymphomas Proceedings of American Association for Cancer Research 35 1994 191
121. A.T. Shad V. Jain I.T. Magrath Small non-cleaved cell lymphomas M.C. Brain Current Therapy in Hematology Oncology ed. 5 1995 Mosby Year Book Inc St. Louis 326
122. T.H. Shawker N.R. Dunnick G.L. Head Ultrasound evaluation of American Burkitt's lymphoma J Clin Ultrasound 7 1979 279 283
123. B. Shiramizu F. Barriga J. Neequaye Patterns of chromosomal breakpoint location in Burkitt's lymphoma: Relevance to geography and EBV association Blood 77 1991 1516 1526
124. F. Sigaux R. Berger A. Bernheim Malignant lymphomas with band 8q24 chromosome abnormality: A morphologic continuum extending from Burkitt's to immunoblastic lymphoma Br J Hematol 57 1984 393 405
125. H. Stein D.-Y. Mason J. Gerdes The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells Blood 66 1985 848 858
126. M. Stetler-Stevenson M. Raffeld P. Cohen Detection of occult follicular lymphoma by specific DNA amplification Blood 72 1988 1822 1825
127. 2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded) Cancer 55 1985 323 336
128. R. Taub I. Kirsch C. Morton Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine, plasmacytoma cells Proc Natl Acad Sci USA 79 1982 7837 7841
129. K.J. Trainer M.J. Brisco J.H. Wan Gene rearrangements in B- and T-lymphoproliferative disease detected by the polymerase chain reaction Blood 78 1991 192 196
130. G.E. Tsokos J.E. Balow R.J. Spiegel Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas Medicine 60 1981 218 229
131. P. Van der Valk C.J.L.M. Meijer R. Willemzo Histiocytic sarcoma (true histiocytic lymphoma): A clinicopathological study of 20 cases Histopathology 8 1984 105 123
132. J.H.J.M. Van Krieken M. Raffeld S. Raghobier Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas Blood 76 1990 797 800
133. V. Vecchi R. Burnelli S. Pileri Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood Med Pediatr Oncol 21 1993 402
134. J. Veenstra R.T. Krediet R. Somers Tumor lysis syndrome and acute renal failure in Burkitt's lymphoma: Description of 2 cases and review of the literature on prevention and management Neth J Med 45 1994 211
135. L. Vodinelich W. Tax Y. Bai A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL) Blood 62 1983 1108 1113
136. D. Wagner J. Kiwanuka B. Edwards Soluble interleukin II receptor levels in patients with undifferentiated and lymphoblastic lymphomas J Clin Onc 5 1987 1262 1274
137. H.J. Weinstein J.R. Cassady R. Levey Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin] and prednisone) for treatment of mediastinal lymphoblastic lymphoma J Clin Oncol 1 1983 537 541
138. H.J. Weinstein E.E. Lack J.R. Cassady APO Therapy for malignant lymphoma of large cell “histiocytic” type of childhood: Analysis of treatment results for 29 patients Blood 64 1984 422 426
139. M. Weintraub M. Adde D. Venzon Severe atypical neuropathy associated with administration of hematopoietic colony stimulating factors and vincristine J Clin Oncol 14 1996 935 940
140. R. West Childhood cancer mortality: International comparisons 1955–1974 World Health Statistics 37 1984 98
141. L. White S.E. Seigel T.C. Quah Non Hodgkins lymphomas in children II: Treatment Crit Rev Oncol Hematol 1 1992 73
142. N. Wollner J.H. Burchenal P.H. Liebermann Non-Hodgkin's lymphoma in children: A comparative study of two modalities of therapy Cancer 37 1976 123 134
143. T. Yano J. Von Kreiken I. Magrath Histogenetic correlations between sub categories of small non-cleaved cell lymphomas Blood 79 1992 1282 1290
144. L. Zech U. Haglund K. Nilsson Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas Int J Cancer 17 1976 47 56
145. J.L. Ziegler I.T. Magrath A.B. Deisseroth Combined modality treatment of Burkitt's lymphoma Cancer Treat Rep 62 1978 2031 2034
146. J.L. Ziegler Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience N Engl J Med 297 1977 75 80
147. J.L. Ziegler Burkitt's lymphoma N Engl J Med 305 1981 734 745